Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

Por Maia, Luis F, Kaeser, Stephan A, Reichwald, Julia, Lambert, Marius, Obermüller, Ulrike, Schelle, Juliane, Odenthal, Jörg, Martus, Peter, Staufenbiel, Matthias, Jucker, Mathias
Publicado no EMBO Mol Med (2015)

Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid

Por Fritschi, Sarah K., Langer, Franziska, Kaeser, Stephan A., Maia, Luis F., Portelius, Erik, Pinotsi, Dorothea, Kaminski, Clemens F., Winkler, David T., Maetzler, Walter, Keyvani, Kathy, Spitzer, Philipp, Wiltfang, Jens, Kaminski Schierle, Gabriele S., Zetterberg, Henrik, Staufenbiel, Matthias, Jucker, Mathias
Publicado no Brain (2014)

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Por Coelho, Teresa, Maia, Luis F., da Silva, Ana Martins, Cruz, Márcia W., Planté-Bordeneuve, Violaine, Suhr, Ole B., Conceiçao, Isabel, Schmidt, Hartmut H.-J., Trigo, Pedro, Kelly, Jeffery W., Labaudinière, Richard, Chan, Jason, Packman, Jeff, Grogan, Donna R.
Publicado em 2013

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

Por Coelho, Teresa, Maia, Luis F., Martins da Silva, Ana, Waddington Cruz, Marcia, Planté-Bordeneuve, Violaine, Lozeron, Pierre, Suhr, Ole B., Campistol, Josep M., Conceição, Isabel Maria, Schmidt, Hartmut H.-J., Trigo, Pedro, Kelly, Jeffery W., Labaudinière, Richard, Chan, Jason, Packman, Jeff, Wilson, Amy, Grogan, Donna R.
Publicado em 2012